Functional alteration of red blood cells by a megadalton protein of Plasmodium falciparum.

Abstract:

:Proteins exported from Plasmodium falciparum parasites into red blood cells (RBCs) interact with the membrane skeleton and contribute to the pathogenesis of malaria. Specifically, exported proteins increase RBC membrane rigidity, decrease deformability, and increase adhesiveness, culminating in intravascular sequestration of infected RBCs (iRBCs). Pf332 is the largest (>1 MDa) known malaria protein exported to the RBC membrane, but its function has not previously been determined. To determine the role of Pf332 in iRBCs, we have engineered and analyzed transgenic parasites with Pf332 either deleted or truncated. Compared with RBCs infected with wild-type parasites, mutants lacking Pf332 were more rigid, were significantly less adhesive to CD36, and showed decreased expression of the major cytoadherence ligand, PfEMP1, on the iRBC surface. These abnormalities were associated with dramatic morphologic changes in Maurer clefts (MCs), which are membrane structures that transport malaria proteins to the RBC membrane. In contrast, RBCs infected with parasites expressing truncated forms of Pf332, although still hyperrigid, showed a normal adhesion profile and morphologically normal MCs. Our results suggest that Pf332 both modulates the level of increased RBC rigidity induced by P falciparum and plays a significant role in adhesion by assisting transport of PfEMP1 to the iRBC surface.

journal_name

Blood

journal_title

Blood

authors

Glenister FK,Fernandez KM,Kats LM,Hanssen E,Mohandas N,Coppel RL,Cooke BM

doi

10.1182/blood-2008-05-157735

subject

Has Abstract

pub_date

2009-01-22 00:00:00

pages

919-28

issue

4

eissn

0006-4971

issn

1528-0020

pii

blood-2008-05-157735

journal_volume

113

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up.

    abstract::Anti-CD22 moxetumomab pasudotox achieved 46% complete remissions (CRs) in previously reported phase 1 testing in relapsed/refractory hairy cell leukemia (HCL; n = 28). The importance of minimal residual disease (MRD) after CR in HCL is unknown. A 21-patient extension cohort received 50 µg/kg every other day for 3 dose...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-09-803072

    authors: Kreitman RJ,Tallman MS,Robak T,Coutre S,Wilson WH,Stetler-Stevenson M,FitzGerald DJ,Santiago L,Gao G,Lanasa MC,Pastan I

    更新日期:2018-05-24 00:00:00

  • The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression.

    abstract::Reactivation of fetal hemoglobin remains a critical goal in the treatment of patients with sickle cell disease and β-thalassemia. Previously, we discovered that silencing of the fetal γ-globin gene requires the erythroid-specific eIF2α kinase heme-regulated inhibitor (HRI), suggesting that HRI might present a pharmaco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005301

    authors: Huang P,Peslak SA,Lan X,Khandros E,Yano JA,Sharma M,Keller CA,Giardine B,Qin K,Abdulmalik O,Hardison RC,Shi J,Blobel GA

    更新日期:2020-06-11 00:00:00

  • Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: Broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations.

    abstract::Severe factor V (FV) deficiency is a rare bleeding disorder, whose genetic bases have been characterized only in a limited number of cases. We investigated 6 unrelated patients with extremely reduced plasma FV levels, associated with a bleeding tendency ranging from moderately severe to severe. Clinical manifestations...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-03-0922

    authors: Montefusco MC,Duga S,Asselta R,Malcovati M,Peyvandi F,Santagostino E,Mannucci PM,Tenchini ML

    更新日期:2003-11-01 00:00:00

  • Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure.

    abstract::In a phase I/II study, 19 patients with advanced tumors but normal hematopoiesis and nine patients with bone marrow failure and prolonged severe cytopenias were treated with recombinant human interleukin-3 (rhIL-3) to assess the toxicity and biological effects of this multipotential hematopoietic growth factor. Doses ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ganser A,Lindemann A,Seipelt G,Ottmann OG,Herrmann F,Eder M,Frisch J,Schulz G,Mertelsmann R,Hoelzer D

    更新日期:1990-08-15 00:00:00

  • Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein.

    abstract::Tissue-type plasminogen activator (t-PA) is approved for treatment of ischemic stroke patients, but it increases the risk of intracranial bleeding (ICB). Previously, we have shown in a mouse stroke model that stromelysin-1 (matrix metalloproteinase-3 [MMP-3]) induced in endothelial cells was critical for ICB induced b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-203919

    authors: Suzuki Y,Nagai N,Yamakawa K,Kawakami J,Lijnen HR,Umemura K

    更新日期:2009-10-08 00:00:00

  • MHC class II and c-kit expression allows rapid enrichment of T-cell progenitors from total bone marrow cells.

    abstract::T-cell progenitors in the embryonic bone marrow express the tyrosine kinase receptor c-kit. RR5, an anti-MHC class II beta chain monoclonal antibody, subdivides this c-kit positive population. Intrathymic transfer experiments showed that most of the T-cell progenitors belong to the MHC class II(+)/c-kit(+) bone marrow...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ody C,Corbel C,Dunon D,Vainio O,Imhof BA

    更新日期:2000-12-01 00:00:00

  • Human platelets exert cytotoxic effects on tumor cells.

    abstract::Monocytes are thought to play a role in host resistance to tumor cell growth in animals and humans. In addition, platelets are known to be involved in tumor metastases. To investigate the interaction of these two cell types and their effect on tumor cells, human monocytes and platelets were examined using an in vitro ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ibele GM,Kay NE,Johnson GJ,Jacob HS

    更新日期:1985-05-01 00:00:00

  • Relationship of a leukemia-associated antigen to the presence of lymphoblasts in the peripheral blood in children with acute lymphocytic leukemia.

    abstract::Peripheral blood samples from 57 children with newly diagnosed E-rosette-negative, surface-immunoglobulin negative acute lymphocytic leukemia (ALL) were studied for the presence of a leukemia-associated antigen (ALLA). Ficoll-Hypaque separated cells were tested using a rabbit antiserum to human null lymphoblasts and a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morgan E,Hsu CC

    更新日期:1981-05-01 00:00:00

  • The relationship between thiopurine methyltransferase activity and genotype in blasts from patients with acute leukemia.

    abstract::The level of expression of the enzyme thiopurine methyltransferase (TPMT) is an important determinant of the metabolism of thiopurines used in the treatment of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Studies in red blood cells (RBC) have shown that TPMT expression displays genetic polymorp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Coulthard SA,Howell C,Robson J,Hall AG

    更新日期:1998-10-15 00:00:00

  • Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection.

    abstract::A recent clinical trial for adrenoleukodystrophy (ALD) showed the efficacy and safety of lentiviral vector (LV) gene transfer in hematopoietic stem progenitor cells. However, several common insertion sites (CIS) were found in patients' cells, suggesting that LV integrations conferred a selective advantage. We performe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-306761

    authors: Biffi A,Bartolomae CC,Cesana D,Cartier N,Aubourg P,Ranzani M,Cesani M,Benedicenti F,Plati T,Rubagotti E,Merella S,Capotondo A,Sgualdino J,Zanetti G,von Kalle C,Schmidt M,Naldini L,Montini E

    更新日期:2011-05-19 00:00:00

  • Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation.

    abstract::Concurrent activation of the T-cell receptor (TCR) and complement regulator CD46 on human CD4+ T lymphocytes induces Tr1-like regulatory T cells that suppress through IL-10 secretion bystander T-cell proliferation. Here we show that, despite their IL-10 production, CD46-induced T-regulatory T cells (Tregs) do not supp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2951

    authors: Barchet W,Price JD,Cella M,Colonna M,MacMillan SK,Cobb JP,Thompson PA,Murphy KM,Atkinson JP,Kemper C

    更新日期:2006-02-15 00:00:00

  • Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction.

    abstract::We sequentially studied bone marrow (BM) samples of 25 patients in complete remission of an acute lymphoblastic leukemia (ALL) using a simplified polymerase chain reaction (PCR) strategy (direct use of the PCR product as a clonogenic probe recognizing rearranged Ig heavy chain sequences) as a first approach. BM aspira...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nizet Y,Van Daele S,Lewalle P,Vaerman JL,Philippe M,Vermylen C,Cornu G,Ferrant A,Michaux JL,Martiat P

    更新日期:1993-09-01 00:00:00

  • In vitro regulation of granulopoiesis in human leukemia: application of an assay for colony-inhibiting cells.

    abstract::We describe two assays to detect the action of colony-inhibiting cells. In the first assay, we used a simple density separation technique to remove dense neutrophils (PMN) from suspensions of blood and of bone marrow cells prior to culture in semisolid agar. Conditions were arranged to ensure that control suspensions ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Broxmeyer HE,Baker FL,Galbraith PR

    更新日期:1976-03-01 00:00:00

  • Extraembryonic expression of EPCR is essential for embryonic viability.

    abstract::The endothelial cell protein C receptor (EPCR) augments protein C activation by the thrombin-thrombomodulin complex. Deletion of the EPCR gene (Procr) in mice leads to embryonic lethality before embryonic day 10 (E10.0). EPCR is detected in the giant trophoblast cells at the feto-maternal boundary from E7.5 and weakly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-01-0406

    authors: Li W,Zheng X,Gu JM,Ferrell GL,Brady M,Esmon NL,Esmon CT

    更新日期:2005-10-15 00:00:00

  • Safety of anticoagulants in children with arterial ischemic stroke.

    abstract::Pediatric arterial ischemic stroke (AIS) is increasingly diagnosed and carries significant risks of recurrence, morbidity, and mortality. Anticoagulant therapy (ACT) is commonly prescribed in childhood AIS. Hemorrhagic complication rates in pediatric stroke are unknown, and adult safety data are of limited applicabili...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-361535

    authors: Schechter T,Kirton A,Laughlin S,Pontigon AM,Finkelstein Y,MacGregor D,Chan A,deVeber G,Brandão LR

    更新日期:2012-01-26 00:00:00

  • Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

    abstract::Circulating endothelial progenitor cells (EPCs) are thought to contribute to angiogenesis following vascular injury, stimulating interest in their ability to mediate therapeutic angiogenesis. However, the number of EPCs in the blood is low, limiting endogenous repair, and a method to rapidly mobilize EPCs has not been...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-06-030577

    authors: Shepherd RM,Capoccia BJ,Devine SM,Dipersio J,Trinkaus KM,Ingram D,Link DC

    更新日期:2006-12-01 00:00:00

  • How I treat acute lymphoblastic leukemia in older adolescents and young adults.

    abstract::At the intersection between children and older adults, the care of adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) poses unique challenges and issues beyond those faced by other age groups. Although the survival of AYA patients is inferior to younger children, growing evidence suggest...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-11-551481

    authors: Curran E,Stock W

    更新日期:2015-06-11 00:00:00

  • Reproductive capacity in iron overloaded women with thalassemia major.

    abstract::The pathophysiology of iron-induced compromised fertility in women with thalassemia major (TM) was evaluated in 26 adult TM females. Low gonadotropin secretion resulted in reduced ovarian antral follicle count and ovarian volume, but levels of anti-müllerian hormone (AMH), a sensitive marker for ovarian reserve indepe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-360271

    authors: Singer ST,Vichinsky EP,Gildengorin G,van Disseldorp J,Rosen M,Cedars MI

    更新日期:2011-09-08 00:00:00

  • Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia.

    abstract::Regulatory T (Tr) cells have the potential to treat immune-mediated disease, but cloning such cells for study from patients with autoimmune disease has proven difficult. Here, we describe autoantigen-specific, interleukin-10 (IL-10)-secreting Tr cell clones recovered ex vivo from a patient with autoimmune hemolytic an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-101345

    authors: Ward FJ,Hall AM,Cairns LS,Leggat AS,Urbaniak SJ,Vickers MA,Barker RN

    更新日期:2008-01-15 00:00:00

  • High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.

    abstract::Thrombopoietin (TPO) is a hematopoietic growth factor that regulates megakaryocytopoiesis and platelet production through binding to its receptor, Mpl, encoded by the c-mpl proto-oncogene. Circulating levels of TPO are regulated by receptor-mediated uptake and degradation. To better understand this mode of TPO regulat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cohen-Solal K,Vitrat N,Titeux M,Vainchenker W,Wendling F

    更新日期:1999-05-01 00:00:00

  • Changing the differentiation program of hematopoietic cells: retinoic acid-induced shift of eosinophil-committed cells to neutrophils.

    abstract::The mechanisms by which hematopoietic progenitor cells become lineage-committed remain poorly understood. A cloned subline of the AML14 cell line (AML14.3D10) that spontaneously differentiates to eosinophilic myelocytes in the absence of cytokine stimulation was obtained by limiting dilution. This subline exhibits aug...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Paul CC,Mahrer S,Tolbert M,Elbert BL,Wong I,Ackerman SJ,Baumann MA

    更新日期:1995-11-15 00:00:00

  • Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.

    abstract::Primary effusion lymphoma (PEL) constitutes a subset of non-Hodgkin lymphoma whose incidence is highly increased in the context of HIV infection. Kaposi sarcoma-associated herpesvirus is the causative agent of PEL. The phosphatidylinositol 3-kinase (PI3K) signaling pathway plays a critical role in cell proliferation a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-251082

    authors: Bhatt AP,Bhende PM,Sin SH,Roy D,Dittmer DP,Damania B

    更新日期:2010-06-03 00:00:00

  • Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis.

    abstract::Hemojuvelin (HJV) positively modulates the iron regulator hepcidin, and its mutations are the major cause of juvenile hemochromatosis (JH), a recessive disease leading to iron overload. Defective HJV reduces hepcidin up-regulation both in humans and in Hjv-deficient mice. To investigate the JH pathogenesis and the fun...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-041004

    authors: Silvestri L,Pagani A,Fazi C,Gerardi G,Levi S,Arosio P,Camaschella C

    更新日期:2007-05-15 00:00:00

  • Speaking a common language in MDS/MPNs.

    abstract::In this issue of Blood, Savona and an international consortium of clinical investigators propose uniform response criteria for treatment trials enrolling adult patients with myelodysplastic/myeloproliferative neoplasms (MDS/MPNs). Such a proposal is needed because new drugs are finally being tested in these rare “over...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-02-626473

    authors: Steensma DP

    更新日期:2015-03-19 00:00:00

  • Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.

    abstract::Recurrent mutations in isocitrate dehydrogenase 2 (IDH2) occur in ∼12% of patients with acute myeloid leukemia (AML). Mutated IDH2 proteins neomorphically synthesize 2-hydroxyglutarate resulting in DNA and histone hypermethylation, which leads to blocked cellular differentiation. Enasidenib (AG-221/CC-90007) is a firs...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-04-779405

    authors: Stein EM,DiNardo CD,Pollyea DA,Fathi AT,Roboz GJ,Altman JK,Stone RM,DeAngelo DJ,Levine RL,Flinn IW,Kantarjian HM,Collins R,Patel MR,Frankel AE,Stein A,Sekeres MA,Swords RT,Medeiros BC,Willekens C,Vyas P,Tosolini A

    更新日期:2017-08-10 00:00:00

  • Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.

    abstract::Many B-lineage-specific genes are down-regulated in Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL). We investigated the involvement of epigenetic modifications in gene silencing in cHL cell lines and in microdissected primary HRS cells. We assessed the expression and methylation status of C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-09-3765

    authors: Ushmorov A,Leithäuser F,Sakk O,Weinhaüsel A,Popov SW,Möller P,Wirth T

    更新日期:2006-03-15 00:00:00

  • Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.

    abstract::Activated protein C (APC) reduces mortality in severe sepsis patients. APC exerts anticoagulant activities via inactivation of factors Va and VIIIa and cytoprotective activities via endothelial protein C receptor and protease-activated receptor-1. APC mutants with selectively altered and opposite activity profiles, th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-183327

    authors: Mosnier LO,Zampolli A,Kerschen EJ,Schuepbach RA,Banerjee Y,Fernández JA,Yang XV,Riewald M,Weiler H,Ruggeri ZM,Griffin JH

    更新日期:2009-06-04 00:00:00

  • Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder.

    abstract::A male neonate with Down's syndrome and congenital myeloproliferative disorder was studied. His blood picture showed the unique coexistence of leukocytosis with matured cells and a large number of blast cells. The in vitro proliferation and differentiation of blast cells into various lineages in the presence of phytoh...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Suda J,Eguchi M,Akiyama Y,Iwama Y,Furukawa T,Sato Y,Miura Y,Suda T,Saito M

    更新日期:1987-02-01 00:00:00

  • ADAMTS13 turns 3.

    abstract::It has now been 3 years since the von Willebrand factor (VWF)-cleaving protease implicated in thrombocytopenic purpura (TTP) pathogenesis was identified as ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13). More than 50 ADAMTS13 mutations resulting in familial TTP have been reported...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2004-10-4097

    authors: Levy GG,Motto DG,Ginsburg D

    更新日期:2005-07-01 00:00:00

  • Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemias.

    abstract::The Philadelphia (Ph1) chromosome is present in greater than 90% of patients with chronic myelogenous leukemia (CML) and in 2% to 20% of those with acute leukemias, for which it is an important prognostic marker too. The chimeric BCR-ABL mRNAs resulting from the translocation encode either a 210-Kd or a 190-Kd protein...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dhingra K,Talpaz M,Riggs MG,Eastman PS,Zipf T,Ku S,Kurzrock R

    更新日期:1991-01-15 00:00:00